Physician profile
Sumita Debroy
NPI 1164538732
$1,117.38
in general payments reported to CMS, 2019-2025
12 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.14 · 2022: $16.95 · 2023: $354 · 2024: $558 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $495.50 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $214.13 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $137.06 | 2024 | Bexsero |
| Ironshore Pharmaceuticals INC. | $71.78 | 2019-2024 | Jornay Pm |
| Modernatx, INC. | $40.55 | 2023 | Moderna Covid-19 Vaccine |
| Sanofi-Aventis U.S. LLC | $28.31 | 2025 | |
| Kyowa Kirin, INC. | $27.20 | 2023 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $24.48 | 2023 | Flumist Quadrivalent |
| Collegium Pharmaceutical, INC. | $23.54 | 2025 | Jornay Pm |
| Nestle Healthcare Nutrition INC. | $21.54 | 2023 | |
| Sanofi Pasteur INC. | $16.95 | 2022 | |
| Adlon Therapeutics L.P. | $16.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumita Debroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.